Canson Capital Partners announced its role as lead financial advisor to CapVest Partners LLP in the acquisition of a majority stake in STADA Arzneimittel AG. CapVest, a prominent international private equity firm, will acquire the majority ownership from Bain Capital and Cinven, who will retain minority stakes.
Founded in 1895, STADA is a major pharmaceutical company with a significant presence across Europe and beyond. The company’s revenue exceeded €4 billion in fiscal year 2024. STADA‘s operations span research and development, manufacturing, and commercialization.
CapVest‘s investment aims to further STADA‘s growth. The firm plans to collaborate with STADA‘s management team to enhance market leadership and expand through innovation, licensing, and mergers and acquisitions.
Canson‘s involvement extended beyond advisory services. The firm co-invested in the transaction through its merchant banking division, representing its second healthcare investment after Chanelle Pharma in 2024. This transaction marks the sixth instance where Canson served as both advisor and co-investor.
Canson‘s team closely monitored STADA and its markets for several years, fostering strong relationships with existing private equity owners. They also partnered with Alan Main, a consumer health expert, who provided strategic insight during due diligence.
This transaction underscores Canson‘s expertise in the healthcare sector, particularly in consumer health. The firm has advised on numerous significant transactions. Canson‘s assets under management exceed $500 million, and it has advised on private equity transactions with an aggregate enterprise value of over $80 billion.
Canson‘s deal team expressed enthusiasm about partnering with CapVest and STADA‘s management. They also recognized the transformative work of Bain Capital and Cinven in establishing STADA‘s market leadership.
Alan Main, Canson‘s operating partner, highlighted the significance of the STADA transaction within the consumer healthcare industry. He praised STADA‘s business model, strong brand portfolio, and leadership team. He stated that he believed this combination would drive future growth.
Canson Capital Partners is an investment and merchant banking firm specializing in alternative capital. The firm connects alternative capital sources with investment opportunities to help clients achieve their strategic goals. Established in 2017, Canson is authorized and regulated by the Financial Conduct Authority.
Related
